DARWIN - Medical Cannabis for Health Professionals 2.0
Medicinal cannabis was legalised in Australia in November 2016. The global legal cannabis market is expected to grow to over US$20 billion by 2020.
There is good clinical evidence that it may be of benefit in chronic pain, MS, nausea in cancer related chemotherapy and drug resistant epilepsy.
Come and learn about the latest trends and scientific research in this exciting new field from a range of experts.DATE AND TIME:
Monday 12 March 2018
6.30pm - 9pm
Charles Darwin University
Blue Room 1.1.01 Auditorium
Ellengowan Dr, Casuarina NT
Paul Mavor - Health House International
Paul is a Perth based pharmacist who has been researching the potential of medicinal cannabis as a treatment for several years. His company was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients. Paul brings a wealth of knowledge from his hands-on research in the U.S., Canada and Israel. www.healthhouse.com.au
Cameron Scadding - Source Certain
Cameron is an expert in supply chain integrity and ensuring that consumers get what is both promised and from the source claimed. www.sourcecertain.com
Rhys Cohen – Senior Project Officer at The Lambert Initiative (Sydney University)
Rhys acts as a key interface between the Lambert Initiative for Cannabinoid Therapeutics and government, regulators, industry and consumers.He responsible for leading a variety of projects within the Lambert Initiative to do with drug policy; the scheduling and rescheduling of cannabis products; NSW Health and TGA/ODC licensing; industry engagement; consumer outreach; and education. He is also responsible for the development of public policy positions for the Lambert Initiative relating to issues such as patient access. www.sydney.edu.au/lambert/
Seminar may qualify for Continuing Education (CE/CPD) points
The organiser will be sent the details of this message.
Sorry, there appears to have been an error. Please try again later.